Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for that
does anyone remember what time they posted the rule36 after the amarin hearing? Every min after that will give me renewed hope
Im assuming Marjac wont comment on this board until a decision is in. Was impressed with the fairness of Judge Newman, a wise lady.
Marjac - thank you. whatever happens you have done us and yourself proud. When you visit Dublin a steak dinner is on me.
While we're waiting - scripts prediction 82,177
has anyone got a link please?
Capt - Are Margit Selvey and Paul Selvey related or is the surname name a coincidence? Could look like we are referring to the same beneficial patients if they are related.
Marjac Go n-éirí an bóthar leat on Friday. A Gaelic greeting to wish you all the luck and success possible.
The truth will set us free.
Thank you.
Stockvadar - if as a board we put any faith in Stockvadar's rubbish that "the consortium" continues to put on yahoo mb then the board is finished.
Capt - some feedback on latest version
[url][/url][tag] http://www.epadi.com [/tag] - this link looks like a place you can buy a website and not a group of scientific professionals- if you put a link like that in your letter NICE will correctly dismiss your letter. I can send you a screen-print to your private email if you want to see how it looks in Ireland.
2. Also putting the following in will only piss the NICE committee off - it would be best to take this out...
The committee has missed the mark and, in our view, is providing bad and distorted information based upon an incomplete review of the relevant evidence. We are left with concerns that bias, or lack of preparation - or expertise - may have tainted the guidance that might be expected of trusted advisors in grave matters of national health.
3. Stating Nissen is unprofessional despite what we might think is not the way to win friends and influence people - it just makes us appear as a bunch of disgruntled shareholders!
Furthermore, Dr. Nissen, the Primary Investigator in the STRENGTH trial (whose comments regarding mineral oil swayed the committee) unprofessionally and unscientifically tried to pin the blame for the STRENGTH failure on the mineral oil placebo used in REDUCE-IT.
Lizzy241, CaptBeer, Alm2 - Thanks for pulling one reply together. I am drafting an email and will sent to CaptBeer later this evening. It will cover my observations of the meeting.
lizzy241 - i'll need to have a think about cc'ing KM.
Thanks lizzy241 - im going to drop him an email with what i sent KM on NICE observations.
Dr Denner's email address - does anyone have it and I would send my points in my first email today.
Pdude - I understand what you are saying but each of the points i made seemed like Amarin appeared unprepared and unprofessional. They majorly need to up their game.
Also this board tends to have a North American understanding but the British bulldog needs to be addressed in a different way.
UK Nice meeting - update sent to KM 13-01-22
1. A number of committee members referenced side effects of Vazkepa as, bleeding, fish oil flavored burping and constipation. Our company reps retort to this was that bleeding was not fatal. Fishy burping is an emotive symptom and we need to be able to push back better.
2. The Strength trial was referenced a number of times as a negative in association with Reduce-IT. Our company reps didn’t make it crystal clear that Strength trial is EPA and DHA as opposed to Reduce-IT being EPA only.
3. In defense of both Sabine and Hakima allot of technical questions on modelling of MACE outcome over 1,2,3 years came up which unless you were involved in the trail you would struggle to answer.
4. There were a number of outstanding points that AMARIN need to get back to the committee on before a decision on reimbursement is made.
a. One of these which our reps didn’t know was the time to discontinuation and what was the drop off rate after two years.
b. Sabine G of the ERG was looking for time to event analysis/subgroups which she said she hadn’t received (She did state she had just returned to work from holiday)
5. As a simple observation we had a main company rep who didn’t speak English as her first language attending a forum where all those who attended did have English as their first language. In light of the current political challenges with Brexit between France and the UK I wonder if this is our best approach.
6. Hakima was putting her physical hand up a number of times to make a point but the procedure was to “raise your hand” using the zoom emoji. I thought this was basic zoom etiquette that Hakima should have been aware off.
did someone just buy 3.57m shares?
exwannabe - Sabine G who was on the ERG re 88K - her whole issue was wanning. Would the effects of wanning be after 10 years. Basically they want a longer study.
69221
Thanks NS.
Im going to drop KM a note based on my observations from yesterday and he can do as he wants with it.
UK NICE ruling - when do we expect this?
1. Having listened I think Amarin need to come back with additional information so it wont be anytime soon.
2. I was disappointed that we couldnt hit back at the burpy and constipation comments that one committee member made. We didnt clearly explain the difference between the strenght and Reduce IT trials
3. Having a French lead in an English meeting wasnt the best choice for Amarin to make.
Thanks Studythosestocks - agree with your summations.
At no point did the company reps state that REDUCE-IT was an EPA study while Strength was an EPA+DHA study. I think I could have done better!
In fairness to the reps unless they were on the reduce-IT study they might not have had the level of detail that some of the questions required.
Sabine from the ERG is a tough cookie also.
why are company reps, who dont have English as their first language, sent into defend the reduce-IT results at an English committee?
Gary Mc**** - very negative on Vaszepa. He introduced Burping and fish oil into the meeting.
Combo Pill - how long do people think it will take to get it from today's announcement to the pharmacy shelves?
Thanks NS.
Combo pill Thanks NS - so can AMRN just pick one combo and go forward with that?
Have AMRN already tested with a specific statin?
Are the results of that testing applicable to all other statins?
Combo pill question - 1) Do AMARIN have to have agreement with a statin producer before they go ahead with this?
If they don't have an agreement with a statin producer how can they develop this combo?
Pharmacydude and Ziploc_1 - My wife is the only nurse in her ward who hasnt got it. She thinks some blood groups are more resistant to virus than others.
1.57 DOLLARS
UK Cardiologist - His Dad just died. He is against any Pharma trial results. Assumes it is all lies. Ask him about reduceIT- He will slate it without knowing any of the facts. Any Doc who is getting airtime. Tweet him Raf and as about Vazkepa in the UK/Germany.
as a small investor I met JT at the last Dublin AGM in 2019. He said to me it was simply about oxidation. My gut feel was this was a hanger on gathering with lots of rich Americans on the pigs back enjoying the finest of Irish hospitality at shareholders expense. But the word from JT "Oxidation" stuck in my mind. He did come across as a genuinely nice guy, maybe that was his downfall.
Capt - Letter feedback
Thanks for your on going effort.
- The letter is too long.
- Use bullet points.
- Get to the point quicker.
- The Dr is a busy man and isnt interested in our emotional input.
- More than one "and" in a sentence lessens the power of the sentence.
I really appreciate all you put into Amarin and please take the points above in that spirit.
BlinkRx - new partnership
Blink - this is a really good CC. KM is speaking like a customer. I like it.
Marjac, Alm2, North - zoom call suggestion
Guys, thanks for all the effort you are putting into righting the wrong.
Would a zoom call between the 3 of you help clarify and elucidate an agreed position that you are all happy with? In the end it can only help Marjac when he has an oral argument.
Best Wishes and thanks.
Type 1 or Type 2 diabetes - which is vascepa beneficial for and why? TIA
KM told us the price today at the Wainwright presentation...
He had US @ 1 Billion , EU @ 1 Billion and ROW @ 1 Billion
3 Billion in total
so now it is either 3,4, or 5 times earnings for the price
Low range 3*3 = 9 Billion
Med range 4*3 = 12 Billion
High range 5*3 = 15 Billion or greater
Per share I believe this to be $21, $28 or $35
Patience Gentlemen and Ladies...
Joe Rogan needs Vascepa now!
Send the man a bottle of it and a cover note!
https://www.independent.ie/entertainment/radio/podcast-star-joe-rogan-tests-positive-for-covid-19-after-comments-dismissing-vaccines-40810788.html
when will Judge Hall likely report her decision?
mixing my trails and trials up